Algorithm for Individual Prediction of COVID-19-Related Hospitalization Based on Symptoms: Development and Implementation Study.

COVID-19 algorithms digital data health records monitoring system pandemic prediction prediction models risk risk prediction severe outcome symptoms

Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
15 11 2021
Historique:
received: 09 04 2021
accepted: 14 09 2021
revised: 23 06 2021
pubmed: 21 9 2021
medline: 19 11 2021
entrez: 20 9 2021
Statut: epublish

Résumé

The COVID-19 pandemic has placed a huge strain on the health care system globally. The metropolitan area of Milan, Italy, was one of the regions most impacted by the COVID-19 pandemic worldwide. Risk prediction models developed by combining administrative databases and basic clinical data are needed to stratify individual patient risk for public health purposes. This study aims to develop a stratification tool aimed at improving COVID-19 patient management and health care organization. A predictive algorithm was developed and applied to 36,834 patients with COVID-19 in Italy between March 8 and the October 9, 2020, in order to foresee their risk of hospitalization. Exposures considered were age, sex, comorbidities, and symptoms associated with COVID-19 (eg, vomiting, cough, fever, diarrhea, myalgia, asthenia, headache, anosmia, ageusia, and dyspnea). The outcome was hospitalizations and emergency department admissions for COVID-19. Discrimination and calibration of the model were also assessed. The predictive model showed a good fit for predicting COVID-19 hospitalization (C-index 0.79) and a good overall prediction accuracy (Brier score 0.14). The model was well calibrated (intercept -0.0028, slope 0.9970). Based on these results, 118,804 patients diagnosed with COVID-19 from October 25 to December 11, 2020, were stratified into low, medium, and high risk for COVID-19 severity. Among the overall study population, 67,030 (56.42%) were classified as low-risk patients; 43,886 (36.94%), as medium-risk patients; and 7888 (6.64%), as high-risk patients. In all, 89.37% (106,179/118,804) of the overall study population was being assisted at home, 9% (10,695/118,804) was hospitalized, and 1.62% (1930/118,804) died. Among those assisted at home, most people (63,983/106,179, 60.26%) were classified as low risk, whereas only 3.63% (3858/106,179) were classified at high risk. According to ordinal logistic regression, the odds ratio (OR) of being hospitalized or dead was 5.0 (95% CI 4.6-5.4) among high-risk patients and 2.7 (95% CI 2.6-2.9) among medium-risk patients, as compared to low-risk patients. A simple monitoring system, based on primary care data sets linked to COVID-19 testing results, hospital admissions data, and death records may assist in the proper planning and allocation of patients and resources during the ongoing COVID-19 pandemic.

Sections du résumé

BACKGROUND
The COVID-19 pandemic has placed a huge strain on the health care system globally. The metropolitan area of Milan, Italy, was one of the regions most impacted by the COVID-19 pandemic worldwide. Risk prediction models developed by combining administrative databases and basic clinical data are needed to stratify individual patient risk for public health purposes.
OBJECTIVE
This study aims to develop a stratification tool aimed at improving COVID-19 patient management and health care organization.
METHODS
A predictive algorithm was developed and applied to 36,834 patients with COVID-19 in Italy between March 8 and the October 9, 2020, in order to foresee their risk of hospitalization. Exposures considered were age, sex, comorbidities, and symptoms associated with COVID-19 (eg, vomiting, cough, fever, diarrhea, myalgia, asthenia, headache, anosmia, ageusia, and dyspnea). The outcome was hospitalizations and emergency department admissions for COVID-19. Discrimination and calibration of the model were also assessed.
RESULTS
The predictive model showed a good fit for predicting COVID-19 hospitalization (C-index 0.79) and a good overall prediction accuracy (Brier score 0.14). The model was well calibrated (intercept -0.0028, slope 0.9970). Based on these results, 118,804 patients diagnosed with COVID-19 from October 25 to December 11, 2020, were stratified into low, medium, and high risk for COVID-19 severity. Among the overall study population, 67,030 (56.42%) were classified as low-risk patients; 43,886 (36.94%), as medium-risk patients; and 7888 (6.64%), as high-risk patients. In all, 89.37% (106,179/118,804) of the overall study population was being assisted at home, 9% (10,695/118,804) was hospitalized, and 1.62% (1930/118,804) died. Among those assisted at home, most people (63,983/106,179, 60.26%) were classified as low risk, whereas only 3.63% (3858/106,179) were classified at high risk. According to ordinal logistic regression, the odds ratio (OR) of being hospitalized or dead was 5.0 (95% CI 4.6-5.4) among high-risk patients and 2.7 (95% CI 2.6-2.9) among medium-risk patients, as compared to low-risk patients.
CONCLUSIONS
A simple monitoring system, based on primary care data sets linked to COVID-19 testing results, hospital admissions data, and death records may assist in the proper planning and allocation of patients and resources during the ongoing COVID-19 pandemic.

Identifiants

pubmed: 34543227
pii: v7i11e29504
doi: 10.2196/29504
pmc: PMC8594734
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29504

Informations de copyright

©Rossella Murtas, Nuccia Morici, Chiara Cogliati, Massimo Puoti, Barbara Omazzi, Walter Bergamaschi, Antonio Voza, Patrizia Rovere Querini, Giulio Stefanini, Maria Grazia Manfredi, Maria Teresa Zocchi, Andrea Mangiagalli, Carla Vittoria Brambilla, Marco Bosio, Matteo Corradin, Francesca Cortellaro, Marco Trivelli, Stefano Savonitto, Antonio Giampiero Russo. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 15.11.2021.

Références

BMJ Open. 2021 Mar 10;11(3):e046044
pubmed: 33692188
N Engl J Med. 2021 Jan 21;384(3):229-237
pubmed: 33113295
Bol Med Hosp Infant Mex. 2020;77(5):262-273
pubmed: 33064680
J Med Internet Res. 2021 Jan 6;23(1):e23897
pubmed: 33320825
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11
pubmed: 32369429
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
N Engl J Med. 2021 Feb 18;384(7):610-618
pubmed: 33406353
Clin Otolaryngol. 2020 Nov;45(6):914-922
pubmed: 32741085
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
PLoS One. 2020 Jun 23;15(6):e0234765
pubmed: 32574165
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Epidemiol Prev. 2021 Jan-Apr;45(1-2):100-109
pubmed: 33884848
Shanghai Arch Psychiatry. 2018 Jun 25;30(3):207-212
pubmed: 30858674
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Eur J Intern Med. 2021 Feb;84:94-96
pubmed: 33293151
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
Int J Epidemiol. 2021 Mar 3;50(1):64-74
pubmed: 33349845
BMJ. 2020 Oct 20;371:m3731
pubmed: 33082154
Eur J Intern Med. 2021 Apr;86:41-47
pubmed: 33579579
Mayo Clin Proc. 2020 Aug;95(8):1621-1631
pubmed: 32753137
Infect Dis Model. 2020;5:271-281
pubmed: 32289100
J Clin Epidemiol. 2020 Feb;118:93-99
pubmed: 31605731
Biol Proced Online. 2020 Aug 4;22:19
pubmed: 32774178

Auteurs

Rossella Murtas (R)

Epidemiology Unit, Agency for the Protection of Health of the Metropolitan Area of Milan, Milan, Italy.

Nuccia Morici (N)

ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

Chiara Cogliati (C)

ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy.

Massimo Puoti (M)

ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Università degli Studi Milano Bicocca, School of Medicine, Milan, Italy.

Walter Bergamaschi (W)

Agency for the Protection of Health of the Metropolitan Area of Milan, Milan, Italy.

Antonio Voza (A)

IRCCS Humanitas, Rozzano, Italy.

Giulio Stefanini (G)

IRCCS Humanitas, Rozzano, Italy.

Maria Grazia Manfredi (MG)

General Practitioners Group, Azienda Territoriale della Salute, Milan Metropolitan Area, Milan, Italy.
Ordine dei Medici Chirurghi e degli Odontoiatri di Milano, Milan, Italy.

Maria Teresa Zocchi (MT)

General Practitioners Group, Azienda Territoriale della Salute, Milan Metropolitan Area, Milan, Italy.
Ordine dei Medici Chirurghi e degli Odontoiatri di Milano, Milan, Italy.

Andrea Mangiagalli (A)

General Practitioners Group, Azienda Territoriale della Salute, Milan Metropolitan Area, Milan, Italy.
Ordine dei Medici Chirurghi e degli Odontoiatri di Milano, Milan, Italy.

Carla Vittoria Brambilla (CV)

General Practitioners Group, Azienda Territoriale della Salute, Milan Metropolitan Area, Milan, Italy.
Ordine dei Medici Chirurghi e degli Odontoiatri di Milano, Milan, Italy.

Marco Bosio (M)

ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Matteo Corradin (M)

ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Francesca Cortellaro (F)

ASST Santi Paolo and Carlo, Milan, Italy.

Marco Trivelli (M)

ASST Brianza, Vimercate, Italy.

Stefano Savonitto (S)

Ospedale A. Manzoni, Lecco, Italy.

Antonio Giampiero Russo (AG)

Epidemiology Unit, Agency for the Protection of Health of the Metropolitan Area of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH